Ethical pharmaceutical promotion and communications worldwide: Codes and regulations

Philosophy, Ethics, and Humanities in Medicine

Volumn 9, Issue 1, 2014, Pages

  Francer, Jeffrey ^a   Izquierdo, Jose Z ^b   Music, Tamara ^c   Narsai, Kirti ^d   Nikidis, Chrisoula ^e   Simmonds, Heather ^f   Woods, Paul ^g  

^a Pharmaceutical Research and Manufacturers of America   (United States)

^b The National Association of the Pharmaceutical Industry in Spain (Farmaindustria) Code Surveillance Unit   (Spain)

^c International Federation of Pharmaceutical Manufacturers and Associations   (Switzerland)

^d Formally: Pharmaceutical Industry Association of South Africa (PIASA)   (South Africa)

^e Canada's Research Based Pharmaceutical Companies   (Canada)

^f ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY   (United Kingdom)

^g Paul Woods Compliance Ltd   (United Kingdom)

Author keywords

Code compliance; Pharmaceutical industry; Promotion of medicines; Self regulation

Indexed keywords

PRESCRIPTION DRUG;

DRUG INDUSTRY; ETHICS; HUMAN; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; LEGISLATION AND JURISPRUDENCE; MARKETING; SOCIAL CONTROL;

COMMUNICATION; DRUG INDUSTRY; HUMANS; INTERNATIONALITY; MARKETING; PRESCRIPTION DRUGS; SOCIAL CONTROL, INFORMAL;

EID: 84897552867     PISSN: None     EISSN: 17475341     Source Type: Journal    
DOI: 10.1186/1747-5341-9-7     Document Type: Review

References (42)

1. Healthy Skepticism. [http://www.healthyskepticism.org/global/].
2. Brennan D. Speech, Fifth International Pharmaceutical Regulatory and Compliance Congress. Istanbul, 4 May 2011 2011, [http://www.internationalpharmacongress.com/past2011/index.html].
3. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:32001L0083: EN:NOT].
4. Criminal penalties for acts involving Federal health care programs USA: Social Security Administration, 42 U.S.C. § 1320a-7b (b) http://www.ssa.gov/OP_Home/ssact/title11/1128B.htm.
5. Consensus Framework for Ethical Collaboration between Patients' Organisation, Healthcare Professionals and the Pharmaceutical Industry 2014, 2014. [http://www.ifpma.org/fileadmin/content/Publication/2014/Consensus_Frame work-vF.pdf].
6. What are EU directives? http://ec.europa.eu/eu_law/introduction/what_directive_en.htm.
7. United States Department of Justice Foreign Corrupt Practices Act (see 15 U.S.C. §§ 78dd-1, et seq.) http://www.justice.gov/criminal/fraud/fcpa, United States Department of Justice.
8. UK Government Bribery Act 2010 2010, [http://www.legislation.gov.uk/ukpga/2010/23/contents], UK Government.
9. Misbranded drugs and devices USA: Food and Drugs Administration, 21 U.S.C. § 352 http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ucm118003.pdf.
10. Health Canada Drugs and health products: regulatory requirements for advertising [http://hc-sc.gc.ca/dhp-mps/advert-publicit/index-eng.php], Health Canada.
11. Government of Australia Therapeutic Goods Act 1989 1989, [http://www.austlii.edu.au/au/legis/cth/consol_act/tga1989191], Government of Australia.
12. US Food and Drug Administration The Office of Prescription Drug Promotion (OPDP) [http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTo bacco/CDER/ucm090142.htm], US Food and Drug Administration.
13. Medicines and Healthcare products Regulatory Agency Advertising of medicines [http://www.mhra.gov.uk/Howweregulate/Medicines/Advertisingofmedicines/i ndex.htm], Medicines and Healthcare products Regulatory Agency.
14. IFPMA Member Association Codes [http://www.ifpma.org/about-ifpma/members/associations.html], IFPMA.
15. International Federation of Pharmaceutical Manufacturers & Associations: IFPMA Code of Practice [http://www.ifpma.org/ethics/ifpma-code-of-practice/about-ifpma-code-of- practice.html].
16. Pharmaceutical Research and Manufacturers of America PhRMA code on interactions with healthcare professionals 2009, Washington DC: PhRMA, http://www.phrma.org/sites/default/files/pdf/phrma_marketing_code_2008.p df, Pharmaceutical Research and Manufacturers of America.
17. International Federation of Pharmaceutical Manufacturers & Associations Code of Pharmaceutical Marketing Practices 2006 2006, Geneva: IFPMA, [http://www.ifpma.org/ethics/ifpma-code-of-practice/about-ifpma-code-of- practice.html], International Federation of Pharmaceutical Manufacturers & Associations.
18. European Federation of Pharmaceutical Industries and Associations EFPIA Code of Practice on the promotion of prescription-only medicines to, and interactions with, healthcare professionals'; 'EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organizations'; Efpia Code on disclosure of transfers of value from pharmaceutical companies to healthcare professionals and healthcare organizations [http://www.efpia.eu/], European Federation of Pharmaceutical Industries and Associations.
19. See, e.g Sherman Antitrust Act, 15 U.S.C. §§ 1-7 as amended by the Clayton Act, 15 U.S.C. § 12-27) See, e.g.
20. PhRMA, Guiding Principles on Direct to Consumer Advertising about Prescription Medicines 2009, http://phrma.org/sites/default/files/pdf/phrmaguidingprinciplesdec08fina l.pdf.
21. Massam D. The development of controls on the promotion of prescription medicines. ESRA Rapporteur 1999,
22. U.S. v. Caronia 2012, 703 F.3d 149 (2d Cir. 2012).
23. Prescription Medicines Code of Practice Authority AUTH/1951/2/07 and AUTH/1952/2/07 and AUTH/1953/2/07 and AUTH/1954/2/07 and AUTH/1955/2/07 -- Pharmacists v AstraZeneca [http://www.pmcpa.org.uk/cases/Pages/1951.aspx], Prescription Medicines Code of Practice Authority.
24. Medicines and Healthcare products Regulatory Agency Advertising complaint: Rosuvastatin 'The new NICE guidance on the use of statins in practice' Pharmaceutical Journal Insert - 20 January 2007 2007, [http://www.mhra.gov.uk/Howweregulate/Medicines/Advertisingofmedicines/A dvertisinginvestigations/CON2030519], Medicines and Healthcare products Regulatory Agency.
25. Clause 18. Association of the British Pharmaceutical Industry ABPI code of practice for the pharmaceutical industry 2011 2011, London: ABPI, Clause 18. Association of the British Pharmaceutical Industry.
26. Clause 17. Association of the British Pharmaceutical Industry ABPI code of practice for the pharmaceutical industry 2014. 2014, London: ABPI, Clause 17. Association of the British Pharmaceutical Industry.
27. IFPMA website/ Member Companies http://www.ifpma.org/about-ifpma/members/companies.html.
28. China Association of Enterprises with Foreign Investment, R&D-Based Pharmaceutical Association Committee RDPAC code of practice on the promotion of pharmaceutical products 2012, Beijing: RDPAC, [http://www.ifpma.org/fileadmin/content/About%20us/2%20Members/Associati ons/Code-China/RDPAC_Code_of_Practice_2012_print_final_web.pdf], China Association of Enterprises with Foreign Investment, R&D-Based Pharmaceutical Association Committee.
29. China Food and Drug Regulatory Information Network Provisions for drug advertisement examination [http://former.sfda.gov.cn/cmsweb/webportal/W45649037/A48335975.html], China Food and Drug Regulatory Information Network.
30. Organisation of Pharmaceutical Producers of India OPPI code of pharmaceutical practices 2012 2012, Mumbai: OPPI, [http://www.indiaoppi.com], Organisation of Pharmaceutical Producers of India.
31. The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1955. 1955, [http://www.medindia.net/indian_health_act/the-drugs-and-magic-remedies- act-1955.htm].
32. Marketing Code Authority of South Africa Code of marketing practice [http://ipasa.co.za/], Marketing Code Authority of South Africa.
33. Consejo de Ética y Transparencia de la Industria Farmacéutica (CETIFARMA) Codes of the pharmaceutical industry established in Mexico 2010, Mexico: Cetifarma, http://www.canifarma.org.mx/descargables/04_cetifarma/03_CODES_OF_THE_PH ARMACEUTICAL_INDUSTRY-2010.pdf, Consejo de Ética y Transparencia de la Industria Farmacéutica (CETIFARMA).
34. International Federation of Pharmaceutical Manufacturers & Associations Global code comparison [http://www.ifpma.org/ethics/ifpma-code-of-practice/global-code-comparis on.html], International Federation of Pharmaceutical Manufacturers & Associations.
35. World Medical Association WMA statement concerning the relationship between physicians and commercial enterprises [http://www.wma.net/en/30publications/10policies/r2/index.html], World Medical Association.
36. EFPIA, IFPMA, JPMA, PhRMA Joint position on the disclosure of clinical trial information via clinical trial registries and databases (updated November 2008) and Joint position on the publication of clinical trial results and the scientific literature 2010, [http://clinicaltrials.ifpma.org/clinicaltrials/fileadmin/files/pdfs/EN/ Revised_Joint_Industry_Position_Nov_2008.pdf] [http://clinicaltrials.ifpma.org/clinicaltrials/fileadmin/files/pdfs/201 00610_Joint_Position_Publication_10Jun2010.pdf], EFPIA, IFPMA, JPMA, PhRMA.
37. EFPIA Code of Practice on relationships between the pharmaceutical industry and patient organizations 2012, [http://www.efpia.eu/documents/23/61/EFPIA-Code-of-Practice-on-relations hips-between-the-pharmaceutical-industry-and-patient-organisations-Amend ed-by-decision-of-the-General-Assembly-in-June-2011].
38. Canada's Research-Based Pharmaceutical Companies (R× & D): Code of Ethical Practices http://www.canadapharma.org/CMFiles/Commitment_to_Ethics/WithHealthCareP rofessionals/Code_of_Ethical_Practices/2012_CodeofEthicalPractices_ENFin al.pdf.
39. Medicines Australia: Code of conduct [http://medicinesaustralia.com.au/code-of-conduct].
40. Prescription Medicines Code of Practice Authority: Digital communications 2012, London, UK: PMCPA, [http://www.pmcpa.org.uk/advice/digital%20communications/Documents/PMCPA %20-%20Digital%20Communications%2023%20October.pdf].
41. Association of Research-Based Pharmaceutical Companies (AIFD, Turkey): Digital communications in the pharmaceutical sector - AİFD User Guid 2012, Istanbul: AIFD, [http://www.aifd.org.tr/en/Hakkimizda/Tanitim-ilkeleri.aspx].
42. See, for example, GlaxoSmithKline Responsibility reports and resources 2014, UK: Glaxo SmithKline, http://www.gsk.com/responsibility/responsibility-reports-and-resources.h tml, See, for example, GlaxoSmithKline.